Lv11
70 积分 2024-09-06 加入
Diagnosis and Management of Multiple Myeloma
1小时前
已完结
How I manage mantle cell lymphoma: indolent versus aggressive disease
1个月前
已完结
Challenges in chimeric antigen receptor-T cell product administration in a high tumor-burden elderly patient with mantle-cell lymphoma
1个月前
已完结
Metabolic and toxicological considerations of Bruton’s tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma
1个月前
已完结
Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms
1个月前
已完结
Non-Covalent Bruton’s Tyrosine Kinase Inhibitors in the Treatment of Chronic Lymphocytic Leukemia
1个月前
已完结
Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non‐Hodgkin lymphoma
1个月前
已完结
Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential Features
1个月前
已完结
皖公网安备34019202002308
